Back to Treatments

Treatment

Bedaquiline + Pretomanid + Linezolid (BPaL Regimen)

1
Conditions
12
Trials
2,000
Participants
38%
Average Safety

Condition Evidence

HIV/AIDS - Extensively drug-resistant Tuberculosis

12 trials · 2,000 participants

88% effectiveness · 38% safety
Bedaquiline + Pretomanid + Linezolid (BPaL Regimen) | DFDA